All Stories

  1. Cluster Headache: Diagnosis, Management, and Treatment in Pediatric Headache
  2. Parental Experiences in Pediatric Multiple Sclerosis: Insights from Quantitative Research
  3. Childhood primary stabbing headache: A double center study
  4. Neuropsychological performances, quality of life, and psychological issues in pediatric onset multiple sclerosis: a narrative review
  5. Gut Microbiota Ecological and Functional Modulation in Post-Stroke Recovery Patients: An Italian Study
  6. Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients
  7. Migraine, Allergy, and Histamine: Is There a Link?
  8. A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome
  9. Visual Disturbances Spectrum in Pediatric Migraine
  10. Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age
  11. Case report: A case of acute disseminated encephalomyelitis after SARS-CoV-2 infection in pediatric patients
  12. Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic
  13. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience
  14. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
  15. Migraine in childhood: Gender differences
  16. Assessment of C Fibers Evoked Potentials in Healthy Subjects by Nd : YAP Laser
  17. Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD
  18. Secondary Narcolepsy as Worsening Sign in a Pediatric Case of Optic Pathway Glioma
  19. Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit
  20. Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History
  21. From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years?
  22. Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review
  23. Epilepsy Course and Developmental Trajectories in STXBP1-DEE
  24. Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex
  25. Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination
  26. Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage
  27. Developmental Regression, Hypertension, and Pink Extremities in Childhood Mercury Poisoning
  28. The Enigma of New Daily Persistent Headache: What Solutions for Pediatric Age?
  29. Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report
  30. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study
  31. Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
  32. How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents
  33. Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns
  34. High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample
  35. The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons
  36. Opsoclonus-Myoclonus Syndrome in Children and Adolescents: A Therapeutic Challenge
  37. Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review
  38. Case Report: Migralepsy: The Two-Faced Janus of Neurology
  39. Can Clinical Neurophysiology Find the Pathophysiological Signature of Migraine in Children?
  40. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes
  41. Contribution of different somatosensory afferent input to subcortical somatosensory evoked potentials in humans
  42. Contribution of different somatosensory afferent input to subcortical somatosensory evoked potentials in humans
  43. Fingolimod in pediatric multiple sclerosis: Six case reports
  44. Symposium Title: The Contribution of Neurophysiology to Migraine: From Basic Mechanisms to the Effects of Novel Treatments
  45. Age‐related sensory neuropathy in patients with spinal muscular atrophy type 1
  46. Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study
  47. Truths and Myths in Pediatric Migraine and Nutrition
  48. Headache in Children and Adolescents: A Focus on Uncommon Headache Disorders
  49. Circulating long non-coding RNA signature in knee osteoarthritis patients with postoperative pain one-year after total knee replacement
  50. Early alterations of cortical thickness and gyrification in migraine without aura: a retrospective MRI study in pediatric patients
  51. Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies
  52. Corrigendum: Major Stress-Related Symptoms During the Lockdown: A Study by the Italian Society of Psychophysiology and Cognitive Neuroscience
  53. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes
  54. Major Stress-Related Symptoms During the Lockdown: A Study by the Italian Society of Psychophysiology and Cognitive Neuroscience
  55. Features and Management of New Daily Persistent Headache in Developmental-Age Patients
  56. Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome
  57. Management of pediatric post-infectious neurological syndromes
  58. Fingolimod in pediatric multiple sclerosis: three case reports
  59. Expanding the Clinical and Mutational Spectrum of the PLP1-Related Hypomyelination of Early Myelinated Structures (HEMS)
  60. Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge
  61. Homotopic reduction in laser‐evoked potential amplitude and laser‐pain rating by abdominal acupuncture
  62. Conditioned pain modulation affects the N2/P2 complex but not the N1 wave: A pilot study with laser‐evoked potentials
  63. Cyclic Vomiting Syndrome in Children
  64. I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children
  65. Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine
  66. Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study
  67. Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
  68. Pearl and pitfalls in brain functional analysis by event-related potentials: a narrative review by the Italian Psychophysiology and Cognitive Neuroscience Society on methodological limits and clinical reliability—part II
  69. Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity?
  70. Methodological limits and clinical reliability of ERPs.
  71. Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study
  72. ZNRD1‐AS and RP11‐819C21.1 long non‐coding RNA changes following painful laser stimulation correlate with laser‐evoked potential amplitude and habituation in healthy subjects: A pilot study
  73. Preoperative serum circulating microRNAs as potential biomarkers for chronic postoperative pain after total knee replacement
  74. Editorial: Clinical and Pathophysiological Peculiarities of Headache in Children and Adolescents
  75. Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome
  76. First Attack and Clinical Presentation of Hemiplegic Migraine in Pediatric Age: A Multicenter Retrospective Study and Literature Review
  77. T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica
  78. Pain in cervical dystonia: Evidence of abnormal inhibitory control
  79. Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?
  80. Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis
  81. Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study
  82. Cooling the skin for assessing small-fibre function
  83. A Delphi consensus statement of the Neuropathic Pain Special Interest Group of the Italian Neurological Society on pharmacoresistant neuropathic pain
  84. Cerebellar Transcranial Direct Current Stimulation (ctDCS) Ameliorates Phantom Limb Pain and Non-painful Phantom Limb Sensations
  85. Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria
  86. Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents
  87. Longitudinal gait assessment in a stiff person syndrome
  88. Low-Frequency rTMS of the Primary Motor Area Does Not Modify the Response of the Cerebral Cortex to Phasic Nociceptive Stimuli
  89. The Italian multiple sclerosis register
  90. Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria
  91. Laser evoked potential amplitude and laser-pain rating reduction during high-frequency non-noxious somatosensory stimulation
  92. Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations
  93. Maternal Alexithymia and Attachment Style: Which Relationship with Their Children’s Headache Features and Psychological Profile?
  94. Autoimmune Encephalitis in Children
  95. Neurophysiological Comparison Among Tonic, High Frequency, and Burst Spinal Cord Stimulation: Novel Insights Into Spinal and Brain Mechanisms of Action
  96. Two Brothers with Atypical UNC13D-Related Hemophagocytic Lymphohistiocytosis Characterized by Massive Lung and Brain Involvement
  97. Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria
  98. Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State
  99. Experts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta
  100. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents
  101. Skin denervation does not alter cortical potentials to surface concentric electrode stimulation: A comparison with laser evoked potentials and contact heat evoked potentials
  102. IHC Posters - Thursday and Friday
  103. TBC1D24 gene mutations are associated with high risk of sudden unexpected death
  104. Survey on treatments for primary headaches in 13 specialized juvenile Headache Centers: The first multicenter Italian study
  105. Diagnostic accuracy of laser-evoked potentials in diabetic neuropathy
  106. Acupuncture for Pain in Chronic Pancreatitis
  107. Venlafaxine and oxycodone have different effects on spinal and supraspinal activity in man: a somatosensory evoked potential study
  108. Role of the Attachment Style in Determining the Association Between Headache Features and Psychological Symptoms in Migraine Children and Adolescents. An Analytical Observational Case-Control Study
  109. Comorbidity with Fibromyalgia
  110. Missense mutations of CACNA1A are a frequent cause of autosomal dominant nonprogressive congenital ataxia
  111. Expectation to feel more pain disrupts the habituation of laser-pain rating and laser-evoked potential amplitudes
  112. Childhood-onset ATP1A3-related conditions: Report of two new cases of phenotypic spectrum
  113. Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives
  114. Diagnosis of primary headache in children younger than 6 years: A clinical challenge
  115. Alexithymia and psychopathological symptoms in adolescent outpatients and mothers suffering from migraines: a case control study
  116. Warmth and nociceptive evoked potentials in cold-induced sweating syndrome type 1
  117. Focal Mechanical Vibration Does not Change Laser-Pain Perception and Laser-Evoked Potentials: A Pilot Study
  118. Somatosensory cortex excitability: a child is not a small adult
  119. Dorsal column nuclei evoked activity recorded from the human pedunculopontine nucleus
  120. Pain Assessment in Neurodegenerative Diseases
  121. Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives
  122. Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor
  123. Low- and high-frequency subcortical SEP amplitude reduction during pure passive movement
  124. Cerebellar direct current stimulation modulates pain perception in humans
  125. Neurophysiologic peculiarities of pediatric primary headaches
  126. Non headache phenotypes in pediatric age
  127. P028. Childhood migraine, epilepsy and tics: Are there similarities in the psychological profile?
  128. P016. Congenital ataxia, hemiplegic migraine due to a novel mutation of CACNA1A: a case report
  129. P029. Migraine, body weight and psychological factors in children and adolescents
  130. O016. Does migraine follow benign paroxysmal torticollis?
  131. O019. Headache as an emergency in children and adolescents
  132. P047. Paroxysmal episodic hemicrania in a child. A complex differential diagnosis
  133. Abdominal acupuncture reduces laser-evoked potentials in healthy subjects
  134. Cortical inhibition of laser pain and laser-evoked potentials by non-nociceptive somatosensory input
  135. Increased habituation to painful stimuli: a self-protective mechanism during prolonged wakefulness?
  136. Migraine equivalents and related symptoms, psychological profile and headache features: which relationship?
  137. A New Method for Sham-Controlled Acupuncture in Experimental Visceral Pain - a Randomized, Single-Blinded Study
  138. Single-sweep spectral analysis of contact heat evoked potentials: a novel approach to identify altered cortical processing after morphine treatment
  139. Multifraction Radiotherapy for Palliation of Painful Bone Metastases: 20 Gy versus 30 Gy
  140. Impaired pain processing in patients with silent myocardial ischemia
  141. Headache as an Emergency in Children and Adolescents
  142. Structural Focal Temporal Lobe Seizures in a Child With Lipoproteinosis
  143. Migraine Equivalents as Part of Migraine Syndrome in Childhood
  144. Low and high-frequency somatosensory evoked potentials recorded from the human pedunculopontine nucleus
  145. Pharmacological and non-pharmacological treatment of pediatric primary headaches
  146. Trigeminal laser-evoked potentials: A neurophysiological tool to detect post-surgical outcome in trigeminovascular contact neuralgia
  147. Somatosensory system hyperexcitability in alternating hemiplegia of childhood
  148. Altered processing of sensory stimuli in patients with migraine
  149. Functional reorganization of brain networks in patients with painful chronic pancreatitis
  150. Electrophysiology as a tool to unravel the origin of pancreatic pain
  151. Primary headache pathophysiology in children: The contribution of clinical neurophysiology
  152. Different SEP recovery cycle in adolescent migraineurs with exploding or imploding pain
  153. Thinking of anything else does not always reduce pain: It depends on timing
  154. Clinical features, anger management and anxiety: a possible correlation in migraine children
  155. Cluster Headache in Childhood
  156. Peripheral and central nervous contribution to gastrointestinal symptoms in diabetic patients with autonomic neuropathy
  157. Clinical usefulness of laser evoked potentials
  158. Psychophysiological mechanisms underlying spatial attention in children with primary headache
  159. Targeting the Pedunculopontine Nucleus
  160. Erratum for Di Franco A, et al. “Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries” Am J Cardiol 2012;109:1705–1710
  161. Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries
  162. Uncertainty, misunderstanding and the pedunculopontine nucleus: the exhumation of an already buried dispute
  163. The use of muscle biopsy in the diagnosis of undefined ataxia with cerebellar atrophy in children
  164. Habituation to Pain in “Medication Overuse Headache”: A CO2 Laser-Evoked Potential Study
  165. Cerebral excitability is abnormal in patients with painful chronic pancreatitis
  166. Brain activity in rectosigmoid pain: Unravelling conditioning pain modulatory pathways
  167. Pregnancy-induced analgesia: a combined psychophysical and neurophysiological study
  168. Is urinary incontinence a true consequence of deep brain stimulation of the pedunculopontine tegmental nucleus in Parkinson’s disease?
  169. Brain source connectivity reveals the visceral pain network
  170. Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials
  171. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers
  172. How much does the neurophysiological assessment of the nociceptive pathways cost?
  173. Evidence of different spinal pathways for the warmth evoked potentials
  174. Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis
  175. The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms
  176. Absent median nerve P14 far-field somatosensory evoked potential with persistent tibial nerve P30 component in a patient with ischemic pontine lesion
  177. Reply: Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated?
  178. Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated?
  179. FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy–Walker malformation carrying a de novo 8p deletion
  180. Pain-Associated Adaptive Cortical Reorganisation in Chronic Pancreatitis
  181. Triptans other than sumatriptan in child and adolescent migraine: literature review
  182. Chronic paroxysmal hemicrania in paediatric age: report of two cases
  183. Childhood refractory focal epilepsy following acute febrile encephalopathy
  184. Effect of movement on SEPs generated by dorsal column nuclei
  185. Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: A laser-evoked potential study
  186. Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials
  187. Neurophysiological studies in alternating hemiplegia of childhood
  188. Familial hypobetalipoproteinemia: early neurological, hematological, and ocular manifestations in two affected twins responding to vitamin supplementation
  189. Somatosensory system excitability in migraine
  190. Pain perception and laser evoked potentials during menstrual cycle in migraine
  191. Inverse Modeling on Decomposed Electroencephalographic Data: A Way Forward?
  192. The Abnormal Recovery Cycle of Somatosensory Evoked Potential Components in Children with Migraine can be Reversed by Topiramate
  193. Brain-evoked potentials as a tool for diagnosing neuropathic pain
  194. Laser evoked potential recording from intracerebral deep electrodes
  195. Correlation Between Abnormal Brain Excitability and Emotional Symptomatology in Paediatric Migraine
  196. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: Evidence for an abnormal nociceptive processing
  197. Learning potentiates neurophysiological and behavioral placebo analgesic responses
  198. Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X ☆
  199. The Child With Headache in a Pediatric Emergency Department
  200. Abnormal processing of the nociceptive input in Parkinson’s disease: A study with CO2 laser evoked potentials
  201. Seeing the pain of others while being in pain: A laser-evoked potentials study
  202. Pre-stimulus alpha power affects vertex N2–P2 potentials evoked by noxious stimuli
  203. Nociceptive contribution to the evoked potentials after painful intramuscular electrical stimulation
  204. New depth short-latency somatosensory evoked potential (SEP) component recorded in human SI area
  205. Unmasking of presynaptic and postsynaptic high-frequency oscillations in epidural cervical somatosensory evoked potentials during voluntary movement
  206. Brain excitability in migraine: Hyperexcitability or inhibited inhibition?
  207. Parallel spinal pathways generate the middle-latency N1 and the late P2 components of the laser evoked potentials
  208. Inhibitory effect of voluntary movement preparation on cutaneous heat pain and laser-evoked potentials
  209. Pain in Chronic Pancreatitis: The Role of Reorganization in the Central Nervous System
  210. Giant subcortical high-frequency SEPs in idiopathic generalized epilepsy: A protective mechanism against seizures?
  211. Antiepileptic drugs in the preventive treatment of migraine in children and adolescents
  212. Cerebellar damage impairs detection of somatosensory input changes. A somatosensory mismatch-negativity study
  213. Distraction affects frontal alpha rhythms related to expectancy of pain: An EEG study
  214. The “human visceral homunculus” to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon
  215. Brainstem Dysfunction in Alternating Hemiplegia of Childhood
  216. Cerebral processing of painful oesophageal stimulation: a study based on independent component analysis of the EEG
  217. Chapter 17 Laser evoked potentials in primary headaches: a possible clinical or research tool?
  218. Chapter 31 Application of dipole models in exploring somatosensory evoked potential sources
  219. Cortical changes to experimental sensitization of the human esophagus
  220. Effects of transcutaneous electrical nerve stimulation on motor cortex excitability in writer's cramp: Neurophysiological and clinical correlations
  221. Modulation of laser-evoked potentials by experimental cutaneous tonic pain
  222. Attentional load of the primary task influences the frontal but not the temporal generators of mismatch negativity
  223. Is there a role of clinical neurophysiology in primary headache?
  224. Multilevel somatosensory system disinhibition in children with migraine
  225. Short and middle-latency Median Nerve (MN) SEPs recorded by depth electrodes in human pre-SMA and SMA-proper
  226. Increase of brain-stem high-frequency SEP subcomponents during light sleep in seizure-free epileptic patients
  227. Attentional training in elderly subjects affects voluntarily oriented, but not automatic attention: A neurophysiological study
  228. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X
  229. Abnormal cortical pain processing in patients with cardiac syndrome X
  230. Amplitude reduction of the epidural cervical SEPs during voluntary movement
  231. Abnormal cortical pain processing in patients with cardiac syndrome X
  232. Cortical neuroplastic changes to painful colon stimulation in patients with irritable bowel syndrome
  233. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials
  234. Corrigendum to "The effects of aging on selective attention to touch: a reduced inhibitory control in elderly subjects?" [International Journal of Psychophysiology 49 (2003) 75–87]
  235. Segmental inhibition of cutaneous heat sensation and of laser-evoked potentials by experimental muscle pain
  236. Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients
  237. Long-lasting modulation of human motor cortex following prolonged transcutaneous electrical nerve stimulation (TENS) of forearm muscles: evidence of reciprocal inhibition and facilitation
  238. Pain evaluation and management: a survey of Italian radiotherapists
  239. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials
  240. Brain-stem components of high-frequency somatosensory evoked potentials are modulated by arousal changes: nasopharyngeal recordings in healthy humans
  241. Erratum
  242. Dipolar source modelling of brain potentials evoked by painful electrical stimulation of the human sigmoid colon
  243. Parietal generators of low- and high-frequency MN (median nerve) SEPs: data from intracortical human recordings
  244. Assessing somatosensory evoked potential (SEP) generators by human intracranial recordings
  245. Different neuronal contribution to N20 somatosensory evoked potential and to CO2 laser evoked potentials: an intracerebral recording study
  246. Functional assessment of A? and C fibers in patients with Fabry's disease
  247. Plastic interactions between hand and face cortical representations in patients with trigeminal neuralgia: a somatosensory-evoked potentials study
  248. Reduction in amplitude of the subcortical low- and high-frequency somatosensory evoked potentials during voluntary movement: an intracerebral recording study
  249. Brain generators of laser-evoked potentials: from dipoles to functional significance
  250. Short-term plastic changes of the human nociceptive system following acute pain induced by capsaicin
  251. Reduced habituation to experimental pain in migraine patients: a CO2 laser evoked potential study
  252. Influence of cholinergic circuitries in generation of high-frequency somatosensory evoked potentials
  253. The effects of aging on selective attention to touch: a reduced inhibitory control in elderly subjects?
  254. The human supplementary motor area-proper does not receive direct somatosensory inputs from the periphery: data from stereotactic depth somatosensory evoked potential recordings
  255. Effect Of Phasic And Tonic Pain on the Motor System: Neurorehabilitative Implications
  256. Cervical cord dysfunction during neck flexion in Hirayama's disease
  257. Unmyelinated trigeminal pathways as assessed by laser stimuli in humans
  258. Cerebellar ataxia and coenzyme Q10 deficiency
  259. Pain-related modulation of the human motor cortex
  260. Abnormal brain processing of cutaneous pain in patients with chronic migraine
  261. Abnormal gating of somatosensory inputs in essential tremor
  262. On the outcome in stroke patients one year later: the role of atrial fibrillation
  263. Attention-related modifications of ultra-late CO2 laser evoked potentials to human trigeminal nerve stimulation
  264. Dissociated changes of somatosensory evoked low-frequency scalp responses and 600 Hz bursts after single-dose administration of lorazepam
  265. Distinct fronto-central N60 and supra-sylvian N70 middle-latency components of the median nerve SEPs as assessed by scalp topographic analysis, dipolar source modelling and depth recordings
  266. Modality-related scalp responses after electrical stimulation of cutaneous and muscular upper limb afferents in humans
  267. Contribution of GABAergic cortical circuitry in shaping somatosensory evoked scalp responses: specific changes after single-dose administration of tiagabine
  268. Dipolar modelling of the scalp evoked potentials to painful contact heat stimulation of the human skin
  269. Transient inhibition of the human motor cortex by capsaicin-induced pain. A study with transcranial magnetic stimulation
  270. Source generators of the early somatosensory evoked potentials to tibial nerve stimulation: an intracerebral and scalp recording study
  271. Inhibition of motor system excitability at cortical and spinal level by tonic muscle pain
  272. Inhibition of biceps brachii muscle motor area by painful heat stimulation of the skin
  273. Functional changes of the primary somatosensory cortex in patients with unilateral cerebellar lesions
  274. Characterizing somatosensory evoked potential sources with dipole models: Advantages and limitations
  275. Characterizing somatosensory evoked potential sources with dipole models: Advantages and limitations
  276. Dipolar source modeling of the P300 event-related potential after somatosensory stimulation
  277. Long-lasting effect evoked by tonic muscle pain on parietal EEG activity in humans
  278. Unmasking of an early laser evoked potential by a point localization task
  279. Scalp distribution of the earliest cortical somatosensory evoked potential to tibial nerve stimulation: proposal of a new recording montage
  280. Dipolar source modeling of somatosensory evoked potentials to painful and nonpainful median nerve stimulation
  281. Somatosensory evoked potentials after multisegmental lower limb stimulation in focal lesions of the lumbosacral spinal cord
  282. Sources of cortical responses to painful CO 2 laser skin stimulation of the hand and foot in the human brain
  283. Central scalp projection of the N30 SEP source activity after median nerve stimulation
  284. Open-door laminoplasty for cervical stenotic myelopathy: surgical technique and neurophysiological monitoring
  285. Dipolar source modeling of somatosensory evoked potentials to painful and nonpainful median nerve stimulation
  286. Effect of movement on dipolar source activities of somatosensory evoked potentials
  287. Inhibition of the human primary motor area by painful heat stimulation of the skin
  288. Different contribution of joint and cutaneous inputs to early scalp somatosensory evoked potentials
  289. Clinical and neurophysiological abnormalities before and after reconstruction of the anterior cruciate ligament of the knee
  290. Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy
  291. The scalp to earlobe montage as standard in routine SEP recording. Comparison with the non-cephalic reference in patients with lesions of the upper cervical cord
  292. Selective abnormality of the N13 spinal SEP to dermatomal stimulation in patients with cervical monoradiculopathy
  293. Dipolar sources of the early scalp somatosensory evoked potentials to upper limb stimulation
  294. Dissociation induced by voluntary movement between two different components of the centro-parietal P40 SEP to tibial nerve stimulation
  295. Dipolar generators of the early scalp somatosensory evoked potentials to tibial nerve stimulation in human subjects
  296. Abnormalities of somatosensory and motor evoked potentials in adrenomyeloneuropathy: Comparison with magnetic resonance imaging and clinical findings
  297. Ischaemic myelopathy associated with cocaine: clinical, neurophysiological, and neuroradiological features
  298. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement
  299. Functional involvement of central nervous system in mitochondrial disorders
  300. The pathophysiology of giant SEPs in cortical myoclonus: a scalp topography and dipolar source modelling study
  301. Giant central N20-P22 with normal area 3b N20-P20: an argument in favour of an area 3a generator of early median nerve cortical SEPs?
  302. Scalp topography and dipolar source modelling of potentials evoked by CO2 laser stimulation of the hand
  303. Spinal responses to median and tibial nerve stimulation and magnetic resonance imaging in intramedullary cord lesions
  304. Brain-stem somatosensory dysfunction in a case of long-standing left hemispherectomy with removal of the left thalamus: a nasopharyngeal and scalp SEP study
  305. Central nervous system modifications in patients with lesion of the anterior cruciate ligament of the knee
  306. Origin and distribution of P13 and P14 far-field potentials after median nerve stimulation. Scalp, nasopharyngeal and neck recording in healthy subjects and in patients with cervical and cervico-medullary lesions
  307. Recovery after surgery of the spinal N24 SEP in dural arteriovenous malformation of the dorsal cord
  308. The role of upper limb somatosensory evoked potentials in the management of cervical spondylotic myelopathy: preliminary data
  309. Somatosensory evoked potentials after multisegmental upper limb stimulation in diagnosis of cervical spondylotic myelopathy.
  310. N24 spinal response to tibial nerve stimulation and magnetic resonance imaging in lesions of the lumbosacral spinal cord
  311. Segmental dysfunction of the cervical cord revealed by abnormalities of the spinal N13 potential in cervical spondylotic myelopathy